Suchergebnisse - "YO603Y8113"

PubPharm (1.117)

71

Associations of modern initial antiretroviral drug regimens with all-cause mortality in adults with HIV in Europe and North America : a cohort study

enthalten in: The lancet. HIV | 2022

von Trickey, A. | Zhang, L. | Gill, M. | +23

CommentIn: Lancet HIV. 2022 Jun;9(6):e371-e372. - PMID 35659330

72

Third-line antiretroviral therapy, including raltegravir (RAL), darunavir (DRV/r) and/or etravirine (ETR), is well tolerated and achieves durable virologic suppression over 144 weeks in resource-limited settings : ACTG A5288 strategy trial

enthalten in: Journal of the International AIDS Society | 2022

von Avihingsanon, A. | Hughes, M. | Salata, R. | +31

73

Efficacy and safety of dolutegravir or darunavir in combination with lamivudine plus either zidovudine or tenofovir for second-line treatment of HIV infection (NADIA) : week 96 results from a prospective, multicentre, open-label, factorial, randomised, non-inferiority trial

enthalten in: The lancet. HIV | 2022

von Paton, N. | Musaazi, J. | Kityo, C. | +101

CommentIn: Lancet HIV. 2022 Jun;9(6):e368-e369. - PMID 35460602

74

Quality of life and associated factors among people receiving second-line anti-retroviral therapy in Johannesburg, South Africa

enthalten in: BMC infectious diseases | 2022

von Mokgethi, N. | Christofides, N. | Machisa, M. | +2

75

Determination of Acyl-, O-, and N-Glucuronide Using Chemical Derivatization Coupled with Liquid Chromatography-High-Resolution Mass Spectrometry

enthalten in: Drug metabolism and disposition: the biological fate of chemicals | 2022

von Guo, Y. | Shah, A. | Oh, E. | +2

76

Multiple Molecular Dynamics Simulations and Energy Analysis Unravel the Dynamic Properties and Binding Mechanism of Mutants HIV-1 Protease with DRV and CA-p2

enthalten in: Microbiology spectrum | 2022

von Wang, R. | Zheng, Q.

77

Pharmacokinetics of Temsavir, the Active Moiety of the HIV-1 Attachment Inhibitor Prodrug, Fostemsavir, Coadministered with Cobicistat, Etravirine, Darunavir/Cobicistat, or Darunavir/Ritonavir with or without Etravirine in Healthy Participants

enthalten in: Antimicrobial agents and chemotherapy | 2022

von Moore, K. | Thakkar, N. | Magee, M. | +5

78

Mechanism of darunavir binding to monomeric HIV-1 protease : a step forward in the rational design of dimerization inhibitors

enthalten in: Physical chemistry chemical physics : PCCP | 2022

von Ahsan, M. | Pindi, C. | Senapati, S.

79

Evaluation of COVID-19 protease and HIV inhibitors interactions

enthalten in: Acta pharmaceutica (Zagreb, Croatia) | 2022

von Tran, L. | Tam, D. | Elhadad, H. | +2

80

Body mass index increase and weight gain among people living with HIV-1 initiated on single-tablet darunavir/cobicistat/emtricitabine/tenofovir alafenamide or bictegravir/emtricitabine/tenofovir alafenamide in the United States

enthalten in: Current medical research and opinion | 2022

von Emond, B. | Rossi, C. | Côté-Sergent, A. | +5